TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
72.26
+1.13 (1.59%)
Jul 24, 2026, 4:00 PM EDT - Market closed
TransMedics Group Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,497 | 4,169 | 2,096 | 2,579 | 1,984 | 532 | |
Market Cap Growth | -32.88% | 98.88% | -18.72% | 29.99% | 272.55% | -1.54% |
Enterprise Value | 2,899 | 4,200 | 2,278 | 2,700 | 1,850 | 483.84 |
Last Close Price | 72.26 | 121.65 | 62.35 | 78.93 | 61.72 | 19.16 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 16.19 | 24.98 | 61.73 | - | - | - |
Forward PE | 35.46 | 47.40 | 56.70 | - | - | - |
PEG Ratio | - | 0.93 | - | - | - | - |
PS Ratio | 3.93 | 6.88 | 4.75 | 10.67 | 21.23 | 17.60 |
PB Ratio | 5.05 | 8.81 | 9.17 | 18.80 | 10.59 | 7.85 |
P/TBV Ratio | 5.93 | 10.73 | 10.22 | 20.89 | 9.74 | 7.80 |
P/FCF Ratio | 16.50 | 31.21 | - | - | - | - |
P/OCF Ratio | 11.34 | 21.62 | 42.95 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.56 | 6.94 | 5.16 | 11.17 | 19.80 | 15.99 |
EV/EBITDA Ratio | 22.76 | 30.93 | 39.78 | - | - | - |
EV/EBIT Ratio | 30.70 | 38.68 | 60.75 | - | - | - |
EV/FCF Ratio | 19.15 | 31.44 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.71 | 1.07 | 2.26 | 3.75 | 0.35 | 0.65 |
Debt / EBITDA Ratio | 6.78 | 3.83 | 9.05 | - | - | - |
Debt / FCF Ratio | 5.70 | 3.89 | - | - | - | - |
Net Debt / Equity Ratio | 0.81 | 0.07 | 0.80 | 0.88 | -0.71 | -0.72 |
Net Debt / EBITDA Ratio | 3.15 | 0.23 | 3.17 | -5.89 | 4.78 | 1.29 |
Net Debt / FCF Ratio | 2.65 | 0.23 | -2.24 | -0.73 | 2.32 | 1.50 |
Asset Turnover | 0.51 | 0.65 | 0.58 | 0.49 | 0.45 | 0.21 |
Inventory Turnover | 5.27 | 5.09 | 3.95 | 2.70 | 1.59 | 0.68 |
Quick Ratio | 6.01 | 6.41 | 7.25 | 8.34 | 9.67 | 4.23 |
Current Ratio | 6.74 | 7.14 | 8.30 | 9.30 | 10.66 | 5.11 |
Return on Equity (ROE) | 35.55% | 54.24% | 19.39% | -15.42% | -28.39% | -51.49% |
Return on Assets (ROA) | 14.52% | 20.53% | 4.92% | -5.48% | -15.29% | -27.51% |
Return on Invested Capital (ROIC) | 25.97% | 42.04% | 11.12% | -17.28% | -86.34% | -245.79% |
Return on Capital Employed (ROCE) | 8.13% | 12.60% | 5.37% | -6.35% | -17.22% | -31.32% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.88% | 4.00% | 1.62% | - | - | - |
FCF Yield | 6.06% | 3.20% | - | - | - | - |
Buyback Yield / Dilution | -8.45% | -15.12% | -8.30% | -10.02% | -7.02% | -11.80% |
Total Shareholder Return | -8.45% | -15.12% | -8.30% | -10.02% | -7.02% | -11.80% |